Beneficial bacteria inhibit cachexia

Oncotarget

Volumn 7, Issue 11, 2016, Pages 11803-11816

  Varian, Bernard J ^a   Goureshetti, Sravya ^a   Poutahidis, Theofilos ^a,b   Lakritz, Jessica R ^a   Levkovich, Tatiana ^a   Kwok, Caitlin ^a   Teliousis, Konstantinos ^b   Ibrahim, Yassin M ^a   Mirabal, Sheyla ^a   Erdman, Susan E ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Cachexia; Inflammation; Microbe; Probiotic; Sarcopenia

Indexed keywords

FORKHEAD BOX N1 PROTEIN; GROWTH HORMONE; PROBIOTIC AGENT; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; FORKHEAD TRANSCRIPTION FACTOR; WHN PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIUM IDENTIFICATION; CACHEXIA; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; FORKHEAD BOX N1 GENE; GENE; GENE FUNCTION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; LACTOBACILLUS REUTERI; MOLECULAR DYNAMICS; MOUSE; MUSCLE ATROPHY; MUSCLE MASS; NONHUMAN; PROTEIN DETERMINATION; PROTEIN FUNCTION; THYMUS FUNCTION; UPREGULATION; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL PROLIFERATION; CYTOLOGY; GENETICS; LONGEVITY; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; SARCOPENIA; THYMUS;

ANIMALS; CACHEXIA; CELL PROLIFERATION; CELLS, CULTURED; FORKHEAD TRANSCRIPTION FACTORS; LACTOBACILLUS REUTERI; LONGEVITY; MICE; MICE, INBRED C57BL; PROBIOTICS; SARCOPENIA; THYMUS GLAND;

EID: 84962802401     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.7730     Document Type: Article

References (91)

1. Tisdale MJ. Cachexia in cancer patients. Nat Rev Cancer. 2002; 2:862-871.
2. von Haehling S and Anker SD. Treatment of cachexia: an overview of recent developments. J Am Med Dir Assoc. 2014; 15:866-872.
3. Argiles JM, Busquets S, Stemmler B and Lopez-Soriano FJ. Cancer cachexia: understanding the molecular basis. Nat Rev Cancer. 2014; 14:754-762.
4. Schols AM and Gosker HR. The pathophysiology of cachexia in chronic obstructive pulmonary disease. Current opinion in supportive and palliative care. 2009; 3:282-287.
5. Balkwill F and Coussens LM. Cancer: an inflammatory link. Nature. 2004; 431:405-406.
6. Moser AR, Pitot HC and Dove WF. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science. 1990; 247:322-324.
7. Baltgalvis KA, Berger FG, Pena MM, Davis JM, Muga SJ and Carson JA. Interleukin-6 and cachexia in ApcMin/+ mice. Am J Physiol Regul Integr Comp Physiol. 2008; 294:R393-401.
8. Naugler WE and Karin M. The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer. Trends in molecular medicine. 2008; 14:109-119.
9. Serrano AL, Baeza-Raja B, Perdiguero E, Jardi M and Munoz-Canoves P. Interleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy. Cell metabolism. 2008; 7:33-44.
10. Gui J, Mustachio LM, Su DM and Craig RW. Thymus Size and Age-related Thymic Involution: Early Programming, Sexual Dimorphism, Progenitors and Stroma. Aging Dis. 2012; 3:280-290.
11. Li Y, Kundu P, Seow SW, de Matos CT, Aronsson L, Chin KC, Karre K, Pettersson S and Greicius G. Gut microbiota accelerate tumor growth via c-jun and STAT3 phosphorylation in APCMin/+ mice. Carcinogenesis. 2012; 33:1231-1238.
12. Levkovich T, Poutahidis T, Cappelle K, Smith MB, Perrotta A, Alm EJ and Erdman SE. 'Hygienic' Lymphocytes Convey Increased Cancer Risk. Journal of Analytical Oncology. 2014; 3.
13. Son JS, Khair S, Pettet DW, 3rd, Ouyang N, Tian X, Zhang Y, Zhu W, Mackenzie GG, Robertson CE, Ir D, Frank DN, Rigas B and Li E. Altered Interactions between the Gut Microbiome and Colonic Mucosa Precede Polyposis in APCMin/+ Mice. PLoS One. 2015; 10:e0127985.
14. Coletta PL, Muller AM, Jones EA, Muhl B, Holwell S, Clarke D, Meade JL, Cook GP, Hawcroft G, Ponchel F, Lam WK, MacLennan KA, Hull MA, Bonifer C and Markham AF. Lymphodepletion in the ApcMin/+ mouse model of intestinal tumorigenesis. Blood. 2004; 103:1050-1058.
15. Wenz T, Rossi SG, Rotundo RL, Spiegelman BM and Moraes CT. Increased muscle PGC-1alpha expression protects from sarcopenia and metabolic disease during aging. Proc Natl Acad Sci U S A. 2009; 106:20405-20410.
16. Vinciguerra M, Musaro A and Rosenthal N. Regulation of muscle atrophy in aging and disease. Adv Exp Med Biol. 2010; 694:211-233.
17. Brooks SV and Faulkner JA. Contractile properties of skeletal muscles from young, adult and aged mice. J Physiol. 1988; 404:71-82.
18. Ballak SB, Degens H, de Haan A and Jaspers RT. Aging related changes in determinants of muscle force generating capacity: a comparison of muscle aging in men and male rodents. Ageing Res Rev. 2014; 14:43-55.
19. Fearing CM, Melton DW, Lei X, Hancock H, Wang H, Sarwar ZU, Porter L, McHale M, McManus LM and Shireman PK. Increased Adipocyte Area in Injured Muscle With Aging and Impaired Remodeling in Female Mice. J Gerontol A Biol Sci Med Sci. 2015.
20. Romanick M, Thompson LV and Brown-Borg HM. Murine models of atrophy, cachexia, and sarcopenia in skeletal muscle. Biochim Biophys Acta. 2013; 1832:1410-1420.
21. Hori S, Nomura T and Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003; 299:1057-1061.
22. Wing K and Sakaguchi S. Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat Immunol. 2010; 11:7-13.
23. Nishioka T, Shimizu J, Iida R, Yamazaki S and Sakaguchi S. CD4+CD25+Foxp3+ T cells and CD4+CD25-Foxp3+ T cells in aged mice. J Immunol. 2006; 176:6586-6593.
24. Haynes L and Swain SL. Aged-related shifts in T cell homeostasis lead to intrinsic T cell defects. Semin Immunol. 2012; 24:350-355.
25. Taub DD and Longo DL. Insights into thymic aging and regeneration. Immunol Rev. 2005; 205:72-93.
26. Ventevogel MS and Sempowski GD. Thymic rejuvenation and aging. Curr Opin Immunol. 2013; 25:516-522.
27. Guo J, Feng Y, Barnes P, Huang FF, Idell S, Su DM and Shams H. Deletion of FoxN1 in the thymic medullary epithelium reduces peripheral T cell responses to infection and mimics changes of aging. PLoS One. 2012; 7:e34681.
28. Romano R, Palamaro L, Fusco A, Giardino G, Gallo V, Del Vecchio L and Pignata C. FOXN1: A Master Regulator Gene of Thymic Epithelial Development Program. Front Immunol. 2013; 4:187.
29. Zhang Z, Burnley P, Coder B and Su DM. Insights on FoxN1 biological significance and usages of the "nude" mouse in studies of T-lymphopoiesis. International journal of biological sciences. 2012; 8:1156-1167.
30. Anderson G, Lane PJ and Jenkinson EJ. Generating intrathymic microenvironments to establish T-cell tolerance. Nature reviews Immunology. 2007; 7:954-963.
31. Balciunaite G, Keller MP, Balciunaite E, Piali L, Zuklys S, Mathieu YD, Gill J, Boyd R, Sussman DJ and Hollander GA. Wnt glycoproteins regulate the expression of FoxN1, the gene defective in nude mice. Nat Immunol. 2002; 3:1102-1108.
32. Bredenkamp N, Nowell CS and Blackburn CC. Regeneration of the aged thymus by a single transcription factor. Development. 2014; 141:1627-1637.
33. Zook EC, Krishack PA, Zhang S, Zeleznik-Le NJ, Firulli AB, Witte PL and Le PT. Overexpression of Foxn1 attenuates age-associated thymic involution and prevents the expansion of peripheral CD4 memory T cells. Blood. 2011; 118:5723-5731.
34. Athalye-Jape G, Rao S and Patole S. Lactobacillus reuteri DSM 17938 as a Probiotic for Preterm Neonates: A Strain-Specific Systematic Review. JPEN Journal of parenteral and enteral nutrition. 2015.
35. Hou C, Zeng X, Yang F, Liu H and Qiao S. Study and use of the probiotic Lactobacillus reuteri in pigs: a review. Journal of animal science and biotechnology. 2015; 6:14.
36. Ojetti V, Ianiro G, Tortora A, D'Angelo G, Di Rienzo TA, Bibbo S, Migneco A and Gasbarrini A. The effect of Lactobacillus reuteri supplementation in adults with chronic functional constipation: a randomized, double-blind, placebo-controlled trial. Journal of gastrointestinal and liver diseases : JGLD. 2014; 23:387-391.
37. Lakritz JR, Poutahidis T, Levkovich T, Varian BJ, Ibrahim YM, Chatzigiagkos A, Mirabal S, Alm EJ and Erdman SE. Beneficial bacteria stimulate host immune cells to counteract dietary and genetic predisposition to mammary cancer in mice. Int J Cancer. 2014; 135:529-540.
38. Levkovich T, Poutahidis T, Smillie C, Varian BJ, Ibrahim YM, Lakritz JR, Alm EJ and Erdman SE. Probiotic bacteria induce a 'glow of health'. PLoS One. 2013; 8:e53867.
39. Poutahidis T, Kleinewietfeld M, Smillie C, Levkovich T, Perrotta A, Bhela S, Varian BJ, Ibrahim YM, Lakritz JR, Kearney SM, Chatzigiagkos A, Hafler DA, Alm EJ and Erdman SE. Microbial reprogramming inhibits Western diet-associated obesity. PLoS One. 2013; 8:e68596.
40. Poutahidis T, Springer A, Levkovich T, Qi P, Varian BJ, Lakritz JR, Ibrahim YM, Chatzigiagkos A, Alm EJ and Erdman SE. Probiotic microbes sustain youthful serum testosterone levels and testicular size in aging mice. PLoS One. 2014; 9:e84877.
41. Varian BJ, Poutahidis T, Levkovich T, Ibrahim YM, Lakritz JR, Chatzigiagkos A, Scherer-Hoock A, Alm EJ and Erdman SE. Beneficial Bacteria Stimulate Youthful Thyroid Gland Activity. J Obes Weight Loss Ther. 2014; 4.
42. Rook GA and Dalgleish A. Infection, immunoregulation, and cancer. Immunol Rev. 2011; 240:141-159.
43. Belkaid Y and Hand TW. Role of the microbiota in immunity and inflammation. Cell. 2014; 157:121-141.
44. Erdman SE and Poutahidis T. Cancer inflammation and regulatory T cells. Int J Cancer. 2010; 127:768-779.
45. Poutahidis T, Varian BJ, Levkovich T, Lakritz JR, Mirabal S, Kwok C, Ibrahim YM, Kearney SM, Chatzigiagkos A, Alm EJ and Erdman SE. Dietary microbes modulate transgenerational cancer risk. Cancer Res. 2015; 75:1197-1204.
46. Baltgalvis KA, Berger FG, Pena MMO, Davis JM, Muga SJ and Carson JA. Interleukin-6 and cachexia in Apc(Min/+) mice. Am J Physiol-Reg I. 2008; 294:R393-R401.
47. Baltgalvis KA, Berger FG, Pena MM, Davis JM, White JP and Carson JA. Muscle wasting and interleukin-6-induced atrogin-I expression in the cachectic Apc ( Min/+ ) mouse. Pflugers Arch. 2009; 457:989-1001.
48. Briguet A, Courdier-Fruh I, Foster M, Meier T and Magyar JP. Histological parameters for the quantitative assessment of muscular dystrophy in the mdx-mouse. Neuromuscul Disord. 2004; 14:675-682.
49. Rao VP, Poutahidis T, Ge Z, Nambiar PR, Boussahmain C, Wang YY, Horwitz BH, Fox JG and Erdman SE. Innate immune inflammatory response against enteric bacteria Helicobacter hepaticus induces mammary adenocarcinoma in mice. Cancer Res. 2006; 66:7395-7400.
50. Rao VP, Poutahidis T, Ge Z, Nambiar PR, Horwitz BH, Fox JG and Erdman SE. Proinflammatory CD4+ CD45RB(hi) lymphocytes promote mammary and intestinal carcinogenesis in Apc(Min/+) mice. Cancer Res. 2006; 66:57-61.
51. Erdman SE, Rao VP, Olipitz W, Taylor CL, Jackson EA, Levkovich T, Lee CW, Horwitz BH, Fox JG, Ge Z and Poutahidis T. Unifying roles for regulatory T cells and inflammation in cancer. Int J Cancer. 2010; 126:1651-1665.
52. Faubion WA, De Jong YP, Molina AA, Ji H, Clarke K, Wang B, Mizoguchi E, Simpson SJ, Bhan AK and Terhorst C. Colitis is associated with thymic destruction attenuating CD4+25+ regulatory T cells in the periphery. Gastroenterology. 2004; 126:1759-1770.
53. Napolitano LA, Schmidt D, Gotway MB, Ameli N, Filbert EL, Ng MM, Clor JL, Epling L, Sinclair E, Baum PD, Li K, Killian ML, Bacchetti P and McCune JM. Growth hormone enhances thymic function in HIV-1-infected adults. J Clin Invest. 2008; 118:1085-1098.
54. Taub DD, Murphy WJ and Longo DL. Rejuvenation of the aging thymus: growth hormone-mediated and ghrelin-mediated signaling pathways. Current opinion in pharmacology. 2010; 10:408-424.
55. Leslie M. Bulking Up the Immune System: Growth hormone rejuvenates bone marrow, thymus (Immunology). Sci Aging Knowl Environ,. 2002; 4.
56. Tuffaha S, Budihardjo J, Sarhane K, Khosheim M, Song D, Broyles J, Salvatori R, Means K, Higgins J, Shores J, Hoke A, Cooney D, Lee WPE and Brandacher G. Effects of Growth Hormone Therapy on Axonal Regeneration, Muscle Atrophy, Schwann Cell Proliferation and End-Organ Reinnervation Following Nerve Injury and Repair. Plastic and Reconstructive Surgery. 2015; 135:92-93.
57. Poutahidis T, Kearney SM, Levkovich T, Qi P, Varian BJ, Lakritz JR, Ibrahim YM, Chatzigiagkos A, Alm EJ and Erdman SE. Microbial Symbionts Accelerate Wound Healing via the Neuropeptide Hormone Oxytocin. PLoS One. 2013; 8:e78898.
58. Erdman SE, Poutahidis T, Tomczak M, Rogers AB, Cormier K, Plank B, Horwitz BH and Fox JG. CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice. Am J Pathol. 2003; 162:691-702.
59. Erdman SE, Rao VP, Poutahidis T, Ihrig MM, Ge Z, Feng Y, Tomczak M, Rogers AB, Horwitz BH and Fox JG. CD4(+)CD25(+) regulatory lymphocytes require interleukin 10 to interrupt colon carcinogenesis in mice. Cancer Res. 2003; 63:6042-6050.
60. Erdman SE, Rao VP, Poutahidis T, Rogers AB, Taylor CL, Jackson EA, Ge Z, Lee CW, Schauer DB, Wogan GN, Tannenbaum SR and Fox JG. Nitric oxide and TNF-\(alpha\) trigger colonic inflammation and carcinogenesis in Helicobacter hepaticus-infected, Rag2-deficient mice. Proc Natl Acad Sci U S A. 2009.
61. Nagamine CM, Rogers AB, Fox JG and Schauer DB. Helicobacter hepaticus promotes azoxymethane-initiated colon tumorigenesis in BALB/c-IL10-deficient mice. Int J Cancer. 2008; 122:832-838.
62. Arthur JC, Perez-Chanona E, Muhlbauer M, Tomkovich S, Uronis JM, Fan TJ, Campbell BJ, Abujamel T, Dogan B, Rogers AB, Rhodes JM, Stintzi A, Simpson KW, Hansen JJ, Keku TO, Fodor AA, et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science. 2012; 338:120-123.
63. Rao VP, Poutahidis T, Fox JG and Erdman SE. Breast cancer: should gastrointestinal bacteria be on our radar screen? Cancer Res. 2007; 67:847-850.
64. Lakritz JR, Poutahidis T, Mirabal S, Varian BJ, Levkovich T, Ibrahim YM, Ward JM, Teng EC, Fisher B, Parry N, Lesage S, Alberg N, Gourishetti S, Fox JG, Ge Z and Erdman SE. Gut bacteria require neutrophils to promote mammary tumorigenesis. Oncotarget. 2015; 6:9387-9396. doi: 10.18632/oncotarget.3328.
65. Lakritz J, Poutahidis T, Mirabal S, Varian B, Levkovich T, Ibrahim Y, Ward J, Teng E, Fisher B, Parry N, Lesage S, Alberg N, Gourishetti S, Fox J, Ge Z and Erdman S. Gut bacteria infection stimulates neutrophils required for mammary tumorigenesis. Oncotarget. 2015.
66. Buonocore S, Ahern PP, Uhlig HH, Ivanov, II, Littman DR, Maloy KJ and Powrie F. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature. 2010; 464:1371-1375.
67. Rutkowski MR, Stephen TL, Svoronos N, Allegrezza MJ, Tesone AJ, Perales-Puchalt A, Brencicova E, Escovar-Fadul X, Nguyen JM, Cadungog MG, Zhang R, Salatino M, Tchou J, Rabinovich GA and Conejo-Garcia JR. Microbially Driven TLR5-Dependent Signaling Governs Distal Malignant Progression through Tumor-Promoting Inflammation. Cancer Cell. 2015; 27:27-40.
68. DeNardo DG and Coussens LM. Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression. Breast Cancer Res. 2007; 9:212.
69. Coussens LM and Pollard JW. Leukocytes in mammary development and cancer. Cold Spring Harb Perspect Biol. 2011; 3.
70. Jiang X and Shapiro DJ. The immune system and inflammation in breast cancer. Mol Cell Endocrinol. 2014; 382:673-682.
71. Erdman SE and Poutahidis T. Roles for inflammation and regulatory T cells in colon cancer. Toxicologic pathology. 2010; 38:76-87.
72. Karamanavi E, Angelopoulou K, Lavrentiadou S, Tsingotjidou A, Abas Z, Taitzoglou I, Vlemmas I, Erdman SE and Poutahidis T. Urokinase-Type Plasminogen Activator Deficiency Promotes Neoplasmatogenesis in the Colon of Mice. Translational Oncology. 2014; 7:174-187.
73. Doulberis M, Angelopoulou K, Kaldrymidou E, Tsingotjidou A, Abas Z, Erdman SE and Poutahidis T. Cholera-toxin suppresses carcinogenesis in a mouse model of inflammation-driven sporadic colon cancer. Carcinogenesis. 2015; 36:280-290.
74. Gregory AD and Houghton AM. Tumor-associated neutrophils: new targets for cancer therapy. Cancer Res. 2011; 71:2411-2416.
75. Lonkar P and Dedon PC. Reactive species and DNA damage in chronic inflammation: reconciling chemical mechanisms and biological fates. Int J Cancer. 2011; 128:1999-2009.
76. Grosse Y, Baan R, Straif K, Secretan B, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Galichet L, Cogliano V and Group WHOIAfRoCMW. A review of human carcinogens-Part A: pharmaceuticals. Lancet Oncol. 2009; 10:13-14.
77. Shacter E and Weitzman SA. Chronic inflammation and cancer. Oncology (Williston Park). 2002; 16:217-226, 229; discussion 230-212.
78. Pham CT. Neutrophil serine proteases: specific regulators of inflammation. Nature reviews Immunology. 2006; 6:541-550.
79. Galdiero MR, Bonavita E, Barajon I, Garlanda C, Mantovani A and Jaillon S. Tumor associated macrophages and neutrophils in cancer. Immunobiology. 2013; 218:1402-1410.
80. Poutahidis T, Haigis KM, Rao VP, Nambiar PR, Taylor CL, Ge Z, Watanabe K, Davidson A, Horwitz BH, Fox JG and Erdman SE. Rapid reversal of interleukin-6-dependent epithelial invasion in a mouse model of microbially induced colon carcinoma. Carcinogenesis. 2007; 28:2614-2623.
81. Erdman SE, Rao, V.P., Olipitz W, Taylor, C.L., Jackson EJ, Levkovich T, Lee CW, Horwitz BH, Fox JG, Ge Z and Poutahidis T. Unifying roles for regulatory T cells and inflammation in cancer. International Journal of Cancer. 2009; 126:1651-1665.
82. Elabd C, Cousin W, Upadhyayula P, Chen RY, Chooljian MS, Li J, Kung S, Jiang KP and Conboy IM. Oxytocin is an age-specific circulating hormone that is necessary for muscle maintenance and regeneration. Nature communications. 2014; 5:4082.
83. Geenen V, Bodart G, Henry S, Michaux H, Dardenne O, Charlet-Renard C, Martens H and Hober D. Programming of neuroendocrine self in the thymus and its defect in the development of neuroendocrine autoimmunity. Frontiers in neuroscience. 2013; 7:187.
84. Nehls M, Pfeifer D, Schorpp M, Hedrich H and Boehm T. New member of the winged-helix protein family disrupted in mouse and rat nude mutations. Nature. 1994; 372:103-107.
85. Corbeaux T, Hess I, Swann JB, Kanzler B, Haas-Assenbaum A and Boehm T. Thymopoiesis in mice depends on a Foxn1-positive thymic epithelial cell lineage. Proc Natl Acad Sci U S A. 2010; 107:16613-16618.
86. Hetherington CM, Hegan MA. Breeding nude (nu/nu) mice. Lab Anim. 1975; 9:19-20.
87. Amorosi S, Vigliano I, Del Giudice E, Panico L, Maruotti GM, Fusco A, Quarantelli M, Ciccone C, Ursini MV, Martinelli P and Pignata C. Brain alteration in a Nude/SCID fetus carrying FOXN1 homozygous mutation. J Neurol Sci. 2010; 298:121-123.
88. Han X, Chen M, Wang F, Windrem M, Wang S, Shanz S, Xu Q, Oberheim NA, Bekar L, Betstadt S, Silva AJ, Takano T, Goldman SA and Nedergaard M. Forebrain engraftment by human glial progenitor cells enhances synaptic plasticity and learning in adult mice. Cell Stem Cell. 2013; 12:342-353.
89. Buckland J. Botulism beaten. Nature reviews Immunology. 2002; 2:628.
90. Swann JB, Weyn A, Nagakubo D, Bleul CC, Toyoda A, Happe C, Netuschil N, Hess I, Haas-Assenbaum A, Taniguchi Y, Schorpp M and Boehm T. Conversion of the thymus into a bipotent lymphoid organ by replacement of FOXN1 with its paralog, FOXN4. Cell Rep. 2014; 8:1184-1197.
91. Saulnier DM, Santos F, Roos S, Mistretta TA, Spinler JK, Molenaar D, Teusink B and Versalovic J. Exploring metabolic pathway reconstruction and genome-wide expression profiling in Lactobacillus reuteri to define functional probiotic features. PLoS One. 2011; 6:e18783.